{"entity":{"type":"insider","cik":"0001773588","url":"/insider/0001773588","json_url":"/insider/0001773588.json","name":"Townsend Adam J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":23,"first":"2022-07-12","last":"2025-01-30","span_basis":"filed_date"},"name_variants":[{"name":"Townsend Adam J.","source":"filing","n_filings":23,"first_seen":"2022-07-12","last_seen":"2025-01-30"}],"transactions":[{"id":4268190,"accession":"0001127602-25-002387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-002387","line_url":"/filing/0001127602-25-002387#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":695.0,"shares_display":"695","price_per_share":29.5236,"price_display":"29.52","price_state":"stated","total_value":20518.902,"total_display":"20,518.90","total_whole":"20,519","shares_owned_after":84050.0,"shares_owned_after_display":"84,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-01-30","scope":"insider"},{"id":5044868,"accession":"0001127602-25-001845","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001845","line_url":"/filing/0001127602-25-001845#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3323.0,"shares_display":"3,323","price_per_share":30.4255,"price_display":"30.43","price_state":"stated","total_value":101103.9365,"total_display":"101,103.94","total_whole":"101,104","shares_owned_after":84745.0,"shares_owned_after_display":"84,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":4765370,"accession":"0001127602-25-001629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001629","line_url":"/filing/0001127602-25-001629#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2201.0,"shares_display":"2,201","price_per_share":29.9582,"price_display":"29.96","price_state":"stated","total_value":65937.9982,"total_display":"65,938.00","total_whole":"65,938","shares_owned_after":88068.0,"shares_owned_after_display":"88,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-21","scope":"insider"},{"id":5084712,"accession":"0001127602-25-001203","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001203","line_url":"/filing/0001127602-25-001203#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2685.0,"shares_display":"2,685","price_per_share":28.7021,"price_display":"28.70","price_state":"stated","total_value":77065.1385,"total_display":"77,065.14","total_whole":"77,065","shares_owned_after":90269.0,"shares_owned_after_display":"90,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-14","scope":"insider"},{"id":3067674,"accession":"0001127602-24-004734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-004734","line_url":"/filing/0001127602-24-004734#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1148.0,"shares_display":"1,148","price_per_share":67.7669,"price_display":"67.77","price_state":"stated","total_value":77796.4012,"total_display":"77,796.40","total_whole":"77,796","shares_owned_after":92453.0,"shares_owned_after_display":"92,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":3155043,"accession":"0001127602-24-002753","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-002753","line_url":"/filing/0001127602-24-002753#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":906.0,"shares_display":"906","price_per_share":64.1382,"price_display":"64.14","price_state":"stated","total_value":58109.2092,"total_display":"58,109.21","total_whole":"58,109","shares_owned_after":93601.0,"shares_owned_after_display":"93,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":2345738,"accession":"0001127602-24-001960","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-001960","line_url":"/filing/0001127602-24-001960#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3413.0,"shares_display":"3,413","price_per_share":64.996,"price_display":"65.00","price_state":"stated","total_value":221831.348,"total_display":"221,831.35","total_whole":"221,831","shares_owned_after":94507.0,"shares_owned_after_display":"94,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-23","scope":"insider"},{"id":2838335,"accession":"0001127602-24-001434","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-001434","line_url":"/filing/0001127602-24-001434#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2235.0,"shares_display":"2,235","price_per_share":66.8086,"price_display":"66.81","price_state":"stated","total_value":149317.221,"total_display":"149,317.22","total_whole":"149,317","shares_owned_after":97920.0,"shares_owned_after_display":"97,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-17","scope":"insider"},{"id":8525365,"accession":"0001127602-23-028964","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-23-028964","line_url":"/filing/0001127602-23-028964","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110000.0,"shares_display":"110,000","price_per_share":60.811849653636365,"price_display":"60.81","price_state":"stated","total_value":6689303.4619,"total_display":"6,689,303.46","total_whole":"6,689,303","shares_owned_after":118850.0,"shares_owned_after_display":"118,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-05","scope":"insider","n_lines":2},{"id":8730170,"accession":"0001127602-23-014500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-014500","line_url":"/filing/0001127602-23-014500#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":82.71,"price_display":"82.71","price_state":"stated","total_value":413550.0,"total_display":"413,550.00","total_whole":"413,550","shares_owned_after":75995.0,"shares_owned_after_display":"75,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-03","filed_date":"2023-05-04","scope":"insider"},{"id":8002525,"accession":"0001127602-23-012593","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-012593","line_url":"/filing/0001127602-23-012593#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":74.05,"price_display":"74.05","price_state":"stated","total_value":370250.0,"total_display":"370,250.00","total_whole":"370,250","shares_owned_after":75995.0,"shares_owned_after_display":"75,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8649352,"accession":"0001127602-23-009314","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-009314","line_url":"/filing/0001127602-23-009314#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":63.84,"price_display":"63.84","price_state":"stated","total_value":319200.0,"total_display":"319,200.00","total_whole":"319,200","shares_owned_after":75995.0,"shares_owned_after_display":"75,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider"},{"id":8291271,"accession":"0001127602-23-003582","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-003582","line_url":"/filing/0001127602-23-003582#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":55.85,"price_display":"55.85","price_state":"stated","total_value":279250.0,"total_display":"279,250.00","total_whole":"279,250","shares_owned_after":67932.0,"shares_owned_after_display":"67,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-03","filed_date":"2023-02-06","scope":"insider"},{"id":8648947,"accession":"0001127602-23-001004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-001004","line_url":"/filing/0001127602-23-001004#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":50.7,"price_display":"50.70","price_state":"stated","total_value":253500.0,"total_display":"253,500.00","total_whole":"253,500","shares_owned_after":42907.0,"shares_owned_after_display":"42,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":6533813,"accession":"0000899243-22-037834","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-037834","line_url":"/filing/0000899243-22-037834#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":50.38,"price_display":"50.38","price_state":"stated","total_value":251900.0,"total_display":"251,900.00","total_whole":"251,900","shares_owned_after":42907.0,"shares_owned_after_display":"42,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-05","filed_date":"2022-12-07","scope":"insider"},{"id":6620786,"accession":"0000899243-22-035276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-035276","line_url":"/filing/0000899243-22-035276#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":58.54,"price_display":"58.54","price_state":"stated","total_value":292700.0,"total_display":"292,700.00","total_whole":"292,700","shares_owned_after":42907.0,"shares_owned_after_display":"42,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-07","scope":"insider"},{"id":6478567,"accession":"0001127602-22-023726","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-023726","line_url":"/filing/0001127602-22-023726#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":66.69,"price_display":"66.69","price_state":"stated","total_value":333450.0,"total_display":"333,450.00","total_whole":"333,450","shares_owned_after":42907.0,"shares_owned_after_display":"42,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6858725,"accession":"0001127602-22-022149","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-022149","line_url":"/filing/0001127602-22-022149#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":60.38,"price_display":"60.38","price_state":"stated","total_value":301900.0,"total_display":"301,900.00","total_whole":"301,900","shares_owned_after":42907.0,"shares_owned_after_display":"42,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-06","filed_date":"2022-09-07","scope":"insider"},{"id":6650139,"accession":"0001127602-22-021110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-021110","line_url":"/filing/0001127602-22-021110#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":69.0,"price_display":"69.00","price_state":"stated","total_value":862500.0,"total_display":"862,500.00","total_whole":"862,500","shares_owned_after":42907.0,"shares_owned_after_display":"42,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-16","scope":"insider"},{"id":6858610,"accession":"0001127602-22-020889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-020889","line_url":"/filing/0001127602-22-020889#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":67.0,"price_display":"67.00","price_state":"stated","total_value":837500.0,"total_display":"837,500.00","total_whole":"837,500","shares_owned_after":42907.0,"shares_owned_after_display":"42,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-11","filed_date":"2022-08-12","scope":"insider"},{"id":6600164,"accession":"0001127602-22-020738","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-020738","line_url":"/filing/0001127602-22-020738#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":812500.0,"total_display":"812,500.00","total_whole":"812,500","shares_owned_after":42907.0,"shares_owned_after_display":"42,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-09","scope":"insider"},{"id":6703960,"accession":"0001127602-22-020499","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-020499","line_url":"/filing/0001127602-22-020499#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":56.43,"price_display":"56.43","price_state":"stated","total_value":282150.0,"total_display":"282,150.00","total_whole":"282,150","shares_owned_after":37907.0,"shares_owned_after_display":"37,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-04","scope":"insider"},{"id":6886326,"accession":"0001127602-22-019253","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-22-019253","line_url":"/filing/0001127602-22-019253#line-3","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001773588","owner_name":"Townsend Adam J.","owner_display_name":"Townsend Adam J.","owner_url":"/insider/0001773588","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":48.42,"price_display":"48.42","price_state":"stated","total_value":242100.0,"total_display":"242,100.00","total_whole":"242,100","shares_owned_after":42907.0,"shares_owned_after_display":"42,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-11","filed_date":"2022-07-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Officer (Chief Commercial Officer)","n_filings":23,"first_seen":"2022-07-12","last_seen":"2025-01-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001773588","retrieved_at":"2026-08-24T21:20:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}